| Nov 8 |
Monopar Therapeutics GAAP EPS of -$0.37
|
| Nov 8 |
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
|
| Oct 30 |
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
|
| Oct 29 |
Monopar Therapeutics drops 16%, prices $19M offering at $16.25 per share
|
| Oct 29 |
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
|
| Oct 28 |
Monopar Therapeutics proposes public offering of common stock
|
| Oct 28 |
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
|
| Oct 28 |
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
|
| Oct 26 |
Individual investors are Monopar Therapeutics Inc.'s (NASDAQ:MNPR) biggest owners and were rewarded after market cap rose by US$40m last week
|
| Oct 25 |
What's Going On With Monopar Therapeutics Shares Friday?
|
